Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.

Cardiol Res Pract · 2010 · PMC2945641 · PMID 20886058

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

A meta-analysis of twenty trials involving 2195 patients showed summary risk ratio for contrast-related nephropathy to be 0.73 (95% confidence interval: 0.52 to 1.0; P = .08), a nonsignificant trend towards benefit in patients treated with acetylcysteine [ 85 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.